Neumarker Inc.
PrivateLast Round
Grant
Nov 12, 2024
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neumarker Inc. is a biotechnology company that develops AI-powered brain biomarker technology to analyze brain function for precision neuromedicine and CNS drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Mental Health, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neumarker Inc. Comparables
Compare Neumarker Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brainify.AI | 84% | |
| Pabel B.V. | 84% | |
| Cumulus Neuroscience | 78% | |
Neumarker Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 12, 2024 |
Neumarker Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foothill Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Jan 20, 2026
Monthly visitors increased 35% MoM, reaching 1.2K.
Neumarker Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neumarker Inc.'s valuation, stock price, and market status.